As of 2024-07-27, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 24.4x | 23.8x |
| Forward P/E multiples | 19.8x - 25.3x | 21.3x |
| Fair Price | (12.98) - (13.73) | (13.10) |
| Upside | -185.1% - -190.0% | -185.9% |
| Date | EV/EBITDA |